Human LILRB2/CD85d/ILT4 Protein, Accession: Q8N423

/在： /通过：
  • 产品概述
  • 产品规格
  • 运输及存储
  • 品牌声明

    • 产品概述

    产品描述

    Recombinant Human LILRB2/CD85d/ILT4 Protein is expressed from HEK293 with hFc tag at the C-terminal.It contains Gln22-His458.

    Biotinylated

    产品规格

    靶点

    LILRB2/CD85d/ILT4

    分子别名

    CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10

    Accession

    Q8N423

    种属

    Human

    蛋白序列

    Gln22-His458

    分子量

    The protein has a predicted MW of 74.1 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human LILRB2, hFc Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Anti-LILRB2 Antibody, hFc Tag with the EC50 of 16.5ng/ml determined by ELISA (QC Test). The affinity constant of 9.20nM as determined in SPR assay (Biacore T200). See testing image for detail.

    产品标签

    C-hFc

    表达系统

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by SEC-HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产品外观

    Lyophilized

    运输条件

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和稳定性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

    该产品的品牌ChemWhat是Watson的注册商标，由Watson授权江苏沃尔森在中国大陆地区使用，点此访问ChemWhat官网。